Explore PTAB cases, litigation, UPC, and oppositions – All in one place. Find the right case faster with powerful filters and structured results.

Novartis Gene Therapies, Inc. et al. vs. Aventis, Inc. et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-01045

Filing Date 2024-03-04

Decision Type Termination Decision: Post-DI Settlement

PDF Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-01044

Filing Date 2024-03-04

Decision Type Termination Decision: Post-DI Settlement

PDF Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Aventis, Inc. et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-01045

Filing Date 2024-01-17

Decision Type Institution Decision: Granting Institution of Inter Partes Review 35 U.S.C. sec. 314, 37 C.F.R. sec. 42.4

PDF Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-01044

Filing Date 2024-01-09

Decision Type DECISION Granting Institution of Inter Partes Review 35 U.S.C. § 314, 37 C.F.R. § 42.4

PDF Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00609

Filing Date 2023-08-30

Decision Type Institution Decision: Deny

PDF Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-00608

Filing Date 2023-08-30

Decision Type Denying Institution of Inter Partes Review 35 U.S.C. § 314

PDF Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Aventis, Inc. et al.

PTAB-CASES Terminated

Status: Terminated-Settled

Proceeding Number IPR2023-01045

Filing Date 2023-06-30

Cause / Proceeding IPR

Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

PTAB-CASES Terminated

Status: Terminated-Settled

Proceeding Number IPR2023-01044

Filing Date 2023-06-30

Cause / Proceeding IPR

Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

PTAB-CASES Institution Denied

Status: Institution Denied

Proceeding Number IPR2023-00609

Filing Date 2023-02-22

Cause / Proceeding IPR

Track Case View Details

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

PTAB-CASES Institution Denied

Status: Institution Denied

Proceeding Number IPR2023-00608

Filing Date 2023-02-22

Cause / Proceeding IPR

Track Case View Details

Acrux DDS Pty Ltd. et al. vs. Kaken Pharmaceutical Co., Ltd.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2017-00190

Filing Date 2018-06-06

Decision Type Final Written Decision

PDF Track Case View Details

CJ Corporation et al. vs. Ajinomoto Co., Inc.

PTAB-CASES Institution Denied

Status: Institution Denied

Proceeding Number IPR2017-01698

Filing Date 2017-06-30

Cause / Proceeding IPR

Track Case View Details

CJ Corporation et al. vs. Ajinomoto Co., Inc.

PTAB-CASES Institution Denied

Status: Institution Denied

Proceeding Number IPR2017-01551

Filing Date 2017-06-30

Cause / Proceeding IPR

Track Case View Details

Argentum Pharmaceuticals LLC et al. vs. Kaken Pharmaceutical Co., Ltd. et al.

PTAB-CASES Terminated

Status: Terminated-Settled

Proceeding Number IPR2017-01429

Filing Date 2017-05-12

Cause / Proceeding IPR

Track Case View Details

Acrux DDS Pty Ltd. et al. vs. Kaken Pharmaceutical Co., Ltd.

PTAB-CASES Final Written Decision

Status: Final Written Decision

Proceeding Number IPR2017-00190

Filing Date 2016-11-02

Cause / Proceeding IPR

Track Case View Details